Alldred SK, Takwoingi Y, Guo B, Pennant M, Deeks JJ, Neilson JP, et al. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down’s syndrome screening. Cochrane Database of Systematic Reviews 2017; 3: Article No.: CD012600. DOI: 10.1002/14651858.CD012600.Web of ScienceGoogle Scholar
Santorum M, Wright D, Syngelaki A, Karagioti N, Nicolaides KH. Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13. Ultrasound Obstet Gynecol 2017;49:714–20.CrossrefPubMedWeb of ScienceGoogle Scholar
Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obs Gynecol 2017;50:302–14.CrossrefGoogle Scholar
Taylor-Phillips S, Freeman K, Geppert J, Agbebiyi A, Uthman OA, Madan J, et al. Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis. BMJ Open 2016;6:e010002.CrossrefPubMedWeb of ScienceGoogle Scholar
Badeau M, Lindsay C, Blais J, Nshimyumukiza L, Takwoingi Y, Langlois S, et al. Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women. Cochrane Database of Systematic Reviews 2017;11: Article No.: CD011767. DOI: 10.1002/14651858.CD011767.pub2.Web of ScienceGoogle Scholar
Neyt M, Hulstaert F, Gyselaers W. Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis. BMJ Open 2014;4:e005922.PubMedCrossrefWeb of ScienceGoogle Scholar
Bayindir B, Dehaspe L, Brison N, Brady P, Ardui S, Kammoun M, et al. Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management. Eur J Hum Genet 2015;23:1286–93.Web of SciencePubMedCrossrefGoogle Scholar
Brison N, Neofytou M, Dehaspe L, Bayindir B, Van Den Bogaert K, Dardour L, et al. Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing. Prenat Diagn 2018;38:258–66.Web of ScienceCrossrefPubMedGoogle Scholar
Brison N, Van Den Bogaert K, Dehaspe L, van den Oever JME, Janssens K, Blaumeiser B, et al. Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidies. Genet Med 2017;19:306–13.PubMedWeb of ScienceCrossrefGoogle Scholar
Gyselaers WJ, Vereecken AJ, Van Herck EJ, Straetmans DP, De Jonge ET, Ombelet WU, et al. Audit on nuchal translucency thickness measurements in Flanders, Belgium: a plea for methodological standardization. Ultrasound Obstet Gynecol 2004;24:511–5.PubMedCrossrefGoogle Scholar
About the article
Published Online: 2019-05-21
Published in Print: 2019-10-25
Funding Source: KU Leuven
Award identifier / Grant number: C1/018
Funding Source: Horizon 2020 WIDENLIFE
Award identifier / Grant number: 692065
The study was funded by the KU Leuven (C1/018) and the Horizon 2020 WIDENLIFE: 692065 to J.R.V.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Employment or leadership: PV is a senior clinical investigator of the Research Foundation-Flanders (FWO).
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article.